Bio-Gene Technology (ASX:BGT) EPS (Basic) : A$-0.01 (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Bio-Gene Technology EPS (Basic)?

Bio-Gene Technology's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was A$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.01.

Bio-Gene Technology's EPS (Diluted) for the six months ended in Dec. 2024 was A$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.01.

Bio-Gene Technology's EPS without NRI for the six months ended in Dec. 2024 was A$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 10.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Bio-Gene Technology's highest 3-Year average EPS without NRI Growth Rate was 10.30% per year. The lowest was -5.90% per year. And the median was 3.65% per year.

Bio-Gene Technology EPS (Basic) Historical Data

The historical data trend for Bio-Gene Technology's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gene Technology EPS (Basic) Chart

Bio-Gene Technology Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EPS (Basic)

Get a 7-Day Free Trial

-0.02

-0.01

Bio-Gene Technology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial										-0.01	-0.01	-0.01	-0.01	-0.01

Bio-Gene Technology EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bio-Gene Technology's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.409	-	0)	/	185.818
	=	-0.01

Bio-Gene Technology's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.465	-	0)	/	200.654
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

Bio-Gene Technology (ASX:BGT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bio-Gene Technology EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Bio-Gene Technology's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Gene Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Gene Technology Ltd (ASX:BGT) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000

Website

https://www.bio-gene.com.au

Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance. Its products are Flavocide and Qcide which include a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. The group's product has multiple applications across public health, crop protection, grain storage, and consumer use. It provides new options derived from nature to meet market demand for effective and safe pest management solutions.

Bio-Gene Technology Headlines

From GuruFocus

BlackRock Floating Rate Income Trust (BGT) Maintains Monthly Dividend Payout

By GuruFocus News • 04-02-2025

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

By Business Wire Business Wire • 12-20-2021